{"id":1232,"date":"2020-05-25T00:58:00","date_gmt":"2020-05-25T00:58:00","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=1232"},"modified":"2023-08-29T18:02:05","modified_gmt":"2023-08-29T18:02:05","slug":"exopharm-developing-plexaris-deliver-anti-cancer-drug-target-cells","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=1232","title":{"rendered":"Exopharm\u7814\u53d1\u65b0\u578bPlexaris\u4ea7\u54c1\uff0c\u5c06\u6297\u764c\u836f\u7269\u5bfc\u5165\u9776\u7ec6\u80de"},"content":{"rendered":"<p>\u4e34\u5e8a\u9636\u6bb5\u518d\u751f\u836f\u7269\u516c\u53f8<a href=\"http:\/\/smallcaps-production.test\/stocks\/?symbol=EX1&amp;lang=cn\">Exopharm (ASX: EX1)<\/a>\u516c\u5e03\u7684\u6d4b\u8bd5\u7ed3\u679c\u8868\u660e\uff0c\u8be5\u516c\u53f8\u7684Plexaris\u4ea7\u54c1\u901a\u8fc7\u201cLEAP\u6280\u672f\u201d\u7531\u5de5\u7a0b\u5916\u6ccc\u4f53\u7ec4\u6210\uff0c\u80fd\u591f\u6709\u6548\u5730\u5c06\u6cbb\u7597\u836f\u7269\u5bfc\u5165\u76ee\u6807\u7ec6\u80de\u3002<\/p>\n<p>Plexaris\u4f5c\u4e3a\u7b2c\u4e00\u9636\u6bb5\u81c2\u4e1b\u5375\u72b6\u4f24\u53e3\u6108\u5408PLEXOVAL\u8bd5\u9a8c\u7684\u4e00\u90e8\u5206\u5df2\u7ecf\u5728\u4eba\u4f53\u4e0a\u8fdb\u884c\u6d4b\u8bd5\uff0c\u5c3d\u7ba1\u5b83\u5728\u6cbb\u7597\u764c\u75c7\u65b9\u9762\u7684\u591a\u65b9\u9762\u5e94\u7528\u4e5f\u5728\u7814\u7a76\u4e2d\u3002<\/p>\n<p>\u4eca\u5e742\u6708\uff0c<a href=\"http:\/\/smallcaps-production.test\/exopharm-publishes-positive-unique-results-exosome-platform\/?lang=cn\">Exopharm\u4eceEurofins\u7684BioMAP\u6d4b\u8bd5\u9879\u76ee\u4e2d\u83b7\u5f97\u4e86\u53cb\u597d\u7684\u7ed3\u679c<\/a>\uff0c\u8868\u660e\u5176\u5916\u6ccc\u4f53\u5e73\u53f0\u7684\u4f5c\u7528\u673a\u5236\u662f\u5b89\u5168\u7684\uff0c\u4e0e\u5176\u4ed64500\u79cd\u836f\u7269\u76f8\u6bd4\u5177\u6709\u201c\u4e0d\u540c\u7684\u548c\u72ec\u7279\u7684\u6d3b\u6027\u201d\u3002<\/p>\n<p>\u5728\u4eca\u5929\u516c\u5e03\u7684\u6d4b\u8bd5\u7ed3\u679c\u7684\u540c\u65f6\uff0cExopharm\u516c\u53f8\u8fd8\u5ba3\u5e03\u542f\u52a8\u5176\u5de5\u7a0b\u5916\u6ccc\u4f53(EEV)\u5f00\u53d1\u548c\u5408\u4f5c\u9879\u76ee\uff0c\u65e8\u5728\u5229\u7528\u5916\u6ccc\u4f53\u7684\u80fd\u529b\uff0c\u5728\u5404\u79cd\u6cbb\u7597\u5e94\u7528\u4e2d\u5c06\u836f\u7269\u8fd0\u9001\u5230\u7279\u5b9a\u7684\u7ec6\u80de\u3002<\/p>\n<p>\u6839\u636e\u6700\u8fd1\u7684\u4e00\u9879\u4f53\u5916\u7814\u7a76\uff0c\u8f7d\u6709\u6297\u764c\u836f\u7269\u963f\u9709\u7d20\u7684Plexaris\u201c\u6740\u6b7b\u7684\u764c\u7ec6\u80de\u6bd4\u540c\u7b49\u5242\u91cf\u7684\u836f\u7269\u672c\u8eab\u6740\u6b7b\u7684\u764c\u7ec6\u80de\u8981\u591a\u5f97\u591a\u201d\uff0cExopharm\u516c\u53f8\u5ba3\u79f0\uff0c\u7814\u7a76\u7ed3\u679c\u8868\u660e\uff0c\u5176\u8840\u5c0f\u677f\u884d\u751f\u7684\u65b9\u6cd5\u5177\u6709\u5e7f\u6cdb\u7684\u6f5c\u529b\uff0c\u53ef\u7528\u4e8e\u5176\u6297\u764c\u836f\u7269Plexaris\u3002<\/p>\n<h2>\u6539\u8fdb\u73b0\u6709\u836f\u7269<\/h2>\n<p>\u76ee\u524d\uff0c\u963f\u9709\u7d20\u88ab\u5e7f\u6cdb\u5e94\u7528\u4e8e\u4e73\u817a\u764c\u3001\u8180\u80f1\u764c\u3001\u6dcb\u5df4\u7624\u548c\u6025\u6027\u6dcb\u5df4\u7ec6\u80de\u767d\u8840\u75c5\u7684\u5316\u7597\u4e2d\u3002<\/p>\n<p>\u8be5\u836f\u7269\u4e8e1974\u5e74\u5728\u7f8e\u56fd\u9996\u6b21\u83b7\u51c6\u7528\u4e8e\u533b\u7597\uff0c\u81f3\u4eca\u4ecd\u5728\u4e16\u754c\u536b\u751f\u7ec4\u7ec7(WHO)\u7684\u57fa\u672c\u836f\u7269\u6e05\u5355\u4e0a\uff0c\u88ab\u8a89\u4e3a\u201c\u536b\u751f\u7cfb\u7edf\u6240\u9700\u7684\u6700\u5b89\u5168\u548c\u6700\u6709\u6548\u7684\u836f\u7269\u201d\u3002<\/p>\n<p>\u963f\u9709\u7d20\u5728\u5168\u4e16\u754c\u7684\u5e74\u9500\u552e\u989d\u8d85\u8fc710\u4ebf\u7f8e\u5143\uff0c\u5728\u53d1\u5c55\u4e2d\u56fd\u5bb6\u7684\u6279\u53d1\u6210\u672c\u76ee\u524d\u7ea6\u4e3a\u6bcf50\u6beb\u514b4-33\u7f8e\u5143\u3002<\/p>\n<p>\u7136\u800c\uff0c\u63a5\u53d7\u963f\u9709\u7d20\u6cbb\u7597\u7684\u60a3\u8005\u7ecf\u5e38\u62a5\u544a\u4e25\u91cd\u7684\u526f\u4f5c\u7528\uff0c\u5305\u62ec\u9aa8\u9ad3\u6291\u5236\u3001\u5fc3\u810f\u6bd2\u6027\u3001\u8131\u53d1\u3001\u6076\u5fc3\u548c\u5455\u5410\uff0c\u8fd9\u8feb\u4f7fFDA\u7b49\u76d1\u7ba1\u673a\u6784\u9650\u5236\u5242\u91cf\u6c34\u5e73\uff0c\u8bd5\u56fe\u9650\u5236\u60a3\u8005\u7684\u4e0d\u826f\u53cd\u5e94\u3002<\/p>\n<p>Exopharm\u5e0c\u671b\u5b83\u7684Plexodox\u4ea7\u54c1\u65e2\u80fd\u63d0\u9ad8\u963f\u9709\u7d20\u6297\u764c\u7ec6\u80de\u7684\u7597\u6548\uff0c\u53c8\u80fd\u51cf\u5c11\u4e0d\u5fc5\u8981\u7684\u526f\u4f5c\u7528\uff0c\u4ece\u800c\u589e\u52a0\u60a3\u8005\u7684\u6cbb\u7597\u7a97\u53e3\uff0c\u5e76\u6709\u53ef\u80fd\u6539\u5584\u4e34\u5e8a\u7ed3\u679c\u3002<\/p>\n<p>\u201c\u764c\u75c7\u80bf\u7624\u6709\u65f6\u88ab\u79f0\u4e3a\u6c38\u4e0d\u6108\u5408\u7684\u5185\u4f24\u3002\u8840\u5c0f\u677f\u88ab\u5438\u5f15\u5230\u4f24\u53e3\u90e8\u4f4d\uff0c\u56e0\u6b64\u6211\u4eec\u6709\u5145\u5206\u7684\u7406\u7531\u76f8\u4fe1\uff0c\u81c2\u4e1b\u591a\u53ef\u4f18\u5148\u5411\u80bf\u7624\u8f93\u9001\u963f\u9709\u7d20\uff0c\u201dExopharm\u521b\u65b0\u90e8\u95e8\u8d1f\u8d23\u4ebaAndrew Coley\u535a\u58eb\u8868\u793a\u3002<\/p>\n<p>\u5f71\u54cdExopharm\u65b9\u6cd5\u7597\u6548\u5e76\u6700\u7ec8\u51b3\u5b9a\u4e1b\u72b6\u808c\u662f\u5426\u6709\u6548\u7684\u4e00\u4e2a\u5173\u952e\u56e0\u7d20\u662f\u836f\u7269\u7684\u914d\u65b9\u3002<\/p>\n<p>\u963f\u9709\u7d20\u901a\u5e38\u4ee5\u201c\u8102\u8d28\u4f53\u914d\u65b9\u201d\u7684\u5f62\u5f0f\u51fa\u552e\uff0c\u8fd9\u662f\u4e00\u79cd\u836f\u7269\u5236\u5907\u65b9\u6cd5\uff0c\u5728\u5fae\u89c2\u7684\u201c\u7c7b\u8102\u201d\u9897\u7c92\u4e2d\u542b\u6709\u6d3b\u6027\u836f\u7269\u3002\u5728\u8fd9\u79cd\u6539\u53d8\u7684\u5f62\u5f0f\u4e0b\uff0c\u8eab\u4f53\u66f4\u5bb9\u6613\u5438\u6536\u836f\u7269\uff0c\u5e76\u5141\u8bb8\u66f4\u591a\u7684\u836f\u7269\u5230\u8fbe\u8eab\u4f53\u7684\u76ee\u6807\u533a\u57df\uff0c\u5982\u80bf\u7624\u3002<\/p>\n<p>\u8102\u8d28\u4f53\u914d\u65b9\u8fd8\u5ef6\u957f\u4e86\u8be5\u836f\u5728\u4f7f\u7528\u540e\u7684\u5faa\u73af\u534a\u8870\u671f\uff0c\u5e76\u964d\u4f4e\u4e86\u5176\u5fc3\u810f\u6bd2\u6027\u3002<\/p>\n<p>\u8102\u8d28\u4f53\u836f\u7269\u9012\u9001\u7eb3\u7c73\u9897\u7c92\u662f\u5408\u6210\u7684\uff0c\u8fd9\u610f\u5473\u7740\u5b83\u4eec\u53ef\u4ee5\u88ab\u514d\u75ab\u7cfb\u7edf\u9776\u5411\uff0c\u5f15\u53d1\u4e0d\u5229\u7684\u514d\u75ab\u53cd\u5e94\u3001\u514d\u75ab\u6bd2\u6027\u548c\u8102\u8d28\u4f53\u6e05\u9664\u3002<\/p>\n<p>\u201c\u764c\u75c7\u60a3\u8005\u901a\u5e38\u5df2\u7ecf\u901a\u8fc7\u8f93\u6ce8\u8840\u5c0f\u677f\u6765\u62b5\u6d88\u5316\u7597\u7684\u526f\u4f5c\u7528\uff0c\u6240\u4ee5\u6211\u4eec\u77e5\u9053\u5f02\u57fa\u56e0\u8840\u5c0f\u677f\u4e0d\u4ec5\u5b89\u5168\uff0c\u800c\u4e14\u5177\u6709\u6cbb\u7597\u4f5c\u7528\u3002\u201dPlexodox\u5c06\u4e24\u79cd\u7597\u6cd5\u5408\u800c\u4e3a\u4e00\uff0c\u201dExopharm\u516c\u53f8\u7684\u9996\u5e2d\u5546\u52a1\u5b98Chris Baldwin\u535a\u58eb\u8bf4\u3002<\/p>\n<p>\u4ed6\u8865\u5145\u8bf4:\u201c\u6211\u4eec\u7684\u65b9\u6cd5\u662f\uff0c\u4e0e\u5176\u6cbb\u7597\u75c5\u4eba\u7684\u526f\u4f5c\u7528\uff0c\u4e0d\u5982\u4f7f\u7528\u8840\u5c0f\u677f\u7535\u52a8\u6c7d\u8f66\u5728\u764c\u7ec6\u80de\u5185\u90e8\u83b7\u5f97\u963f\u9709\u7d20\u3002\u201d<\/p>\n<p>Exopharm\u516c\u53f8\u516c\u5e03\u7684\u6d4b\u8bd5\u7ed3\u679c\u8fd8\u5904\u4e8e\u65e9\u671f\u9636\u6bb5\uff0c\u4f53\u5916\u7ed3\u679c\u8fd8\u6709\u5f85\u4e8e\u5728\u52a8\u7269\u6a21\u578b\u4e0a\u5f97\u5230\u8bc1\u5b9e\uff0c\u800c\u8be5\u516c\u53f8\u8bc1\u5b9e\uff0c\u5728\u4e1b\u72b6\u591a\u7528\u9014x\u88ab\u63d0\u8bae\u7528\u4e8e\u4eba\u4f53\u8bd5\u9a8c\u4e4b\u524d\uff0c\u8fd8\u9700\u8981\u8fdb\u884c\u989d\u5916\u7684\u6d4b\u8bd5\uff0c\u4f5c\u4e3a\u5f00\u53d1\u8ba1\u5212\u7684\u4e00\u90e8\u5206\u3002<\/p>\n<p>Exopharm\u7684\u80a1\u4ef7\u5728\u65e9\u76d8\u4ea4\u6613\u4e2d\u4e0a\u6da8\u8d85\u8fc730%\uff0c\u8fbe\u52300.29\u6fb3\u5143\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u4e34\u5e8a\u9636\u6bb5\u518d\u751f\u836f\u7269\u516c\u53f8Exopharm (ASX: EX1)\u516c\u5e03\u7684\u6d4b\u8bd5\u7ed3\u679c\u8868\u660e\uff0c\u8be5\u516c\u53f8\u7684Plexaris\u4ea7\u54c1\u901a\u8fc7\u201cLEAP\u6280\u672f\u201d\u7531\u5de5\u7a0b\u5916\u6ccc\u4f53\u7ec4\u6210\uff0c\u80fd\u591f\u6709\u6548\u5730\u5c06\u6cbb\u7597\u836f\u7269\u5bfc\u5165\u76ee\u6807\u7ec6\u80de\u3002 Plexaris\u4f5c\u4e3a\u7b2c\u4e00\u9636\u6bb5\u81c2\u4e1b\u5375\u72b6\u4f24\u53e3\u6108\u5408PLEXOVAL\u8bd5\u9a8c\u7684\u4e00\u90e8\u5206\u5df2\u7ecf\u5728\u4eba\u4f53\u4e0a\u8fdb\u884c\u6d4b\u8bd5\uff0c\u5c3d\u7ba1\u5b83\u5728\u6cbb\u7597\u764c\u75c7\u65b9\u9762\u7684\u591a\u65b9\u9762\u5e94\u7528\u4e5f\u5728\u7814\u7a76\u4e2d\u3002 \u4eca\u5e742\u6708\uff0cExopharm\u4eceEurofins\u7684BioMAP\u6d4b\u8bd5\u9879\u76ee\u4e2d\u83b7\u5f97\u4e86\u53cb\u597d\u7684\u7ed3\u679c\uff0c\u8868\u660e\u5176\u5916\u6ccc\u4f53\u5e73\u53f0\u7684\u4f5c\u7528\u673a\u5236\u662f\u5b89\u5168\u7684\uff0c\u4e0e\u5176\u4ed64500\u79cd\u836f\u7269\u76f8\u6bd4\u5177\u6709\u201c\u4e0d\u540c\u7684\u548c\u72ec\u7279\u7684\u6d3b\u6027\u201d\u3002 \u5728\u4eca\u5929\u516c\u5e03\u7684\u6d4b\u8bd5\u7ed3\u679c\u7684\u540c\u65f6\uff0cExopharm\u516c\u53f8\u8fd8\u5ba3\u5e03\u542f\u52a8\u5176\u5de5\u7a0b\u5916\u6ccc\u4f53(EEV)\u5f00\u53d1\u548c\u5408\u4f5c\u9879\u76ee\uff0c\u65e8\u5728\u5229\u7528\u5916\u6ccc\u4f53\u7684\u80fd\u529b\uff0c\u5728\u5404\u79cd\u6cbb\u7597\u5e94\u7528\u4e2d\u5c06\u836f\u7269\u8fd0\u9001\u5230\u7279\u5b9a\u7684\u7ec6\u80de\u3002 \u6839\u636e\u6700\u8fd1\u7684\u4e00\u9879\u4f53\u5916\u7814\u7a76\uff0c\u8f7d\u6709\u6297\u764c\u836f\u7269\u963f\u9709\u7d20\u7684Plexaris\u201c\u6740\u6b7b\u7684\u764c\u7ec6\u80de\u6bd4\u540c\u7b49\u5242\u91cf\u7684\u836f\u7269\u672c\u8eab\u6740\u6b7b\u7684\u764c\u7ec6\u80de\u8981\u591a\u5f97\u591a\u201d\uff0cExopharm\u516c\u53f8\u5ba3\u79f0\uff0c\u7814\u7a76\u7ed3\u679c\u8868\u660e\uff0c\u5176\u8840\u5c0f\u677f\u884d\u751f\u7684\u65b9\u6cd5\u5177\u6709\u5e7f\u6cdb\u7684\u6f5c\u529b\uff0c\u53ef\u7528\u4e8e\u5176\u6297\u764c\u836f\u7269Plexaris\u3002 \u6539\u8fdb\u73b0\u6709\u836f\u7269 \u76ee\u524d\uff0c\u963f\u9709\u7d20\u88ab\u5e7f\u6cdb\u5e94\u7528\u4e8e\u4e73\u817a\u764c\u3001\u8180\u80f1\u764c\u3001\u6dcb\u5df4\u7624\u548c\u6025\u6027\u6dcb\u5df4\u7ec6\u80de\u767d\u8840\u75c5\u7684\u5316\u7597\u4e2d\u3002 \u8be5\u836f\u7269\u4e8e1974\u5e74\u5728\u7f8e\u56fd\u9996\u6b21\u83b7\u51c6\u7528\u4e8e\u533b\u7597\uff0c\u81f3\u4eca\u4ecd\u5728\u4e16\u754c\u536b\u751f\u7ec4\u7ec7(WHO)\u7684\u57fa\u672c\u836f\u7269\u6e05\u5355\u4e0a\uff0c\u88ab\u8a89\u4e3a\u201c\u536b\u751f\u7cfb\u7edf\u6240\u9700\u7684\u6700\u5b89\u5168\u548c\u6700\u6709\u6548\u7684\u836f\u7269\u201d\u3002 \u963f\u9709\u7d20\u5728\u5168\u4e16\u754c\u7684\u5e74\u9500\u552e\u989d\u8d85\u8fc710\u4ebf\u7f8e\u5143\uff0c\u5728\u53d1\u5c55\u4e2d\u56fd\u5bb6\u7684\u6279\u53d1\u6210\u672c\u76ee\u524d\u7ea6\u4e3a\u6bcf50\u6beb\u514b4-33\u7f8e\u5143\u3002 \u7136\u800c\uff0c\u63a5\u53d7\u963f\u9709\u7d20\u6cbb\u7597\u7684\u60a3\u8005\u7ecf\u5e38\u62a5\u544a\u4e25\u91cd\u7684\u526f\u4f5c\u7528\uff0c\u5305\u62ec\u9aa8\u9ad3\u6291\u5236\u3001\u5fc3\u810f\u6bd2\u6027\u3001\u8131\u53d1\u3001\u6076\u5fc3\u548c\u5455\u5410\uff0c\u8fd9\u8feb\u4f7fFDA\u7b49\u76d1\u7ba1\u673a\u6784\u9650\u5236\u5242\u91cf\u6c34\u5e73\uff0c\u8bd5\u56fe\u9650\u5236\u60a3\u8005\u7684\u4e0d\u826f\u53cd\u5e94\u3002 Exopharm\u5e0c\u671b\u5b83\u7684Plexodox\u4ea7\u54c1\u65e2\u80fd\u63d0\u9ad8\u963f\u9709\u7d20\u6297\u764c\u7ec6\u80de\u7684\u7597\u6548\uff0c\u53c8\u80fd\u51cf\u5c11\u4e0d\u5fc5\u8981\u7684\u526f\u4f5c\u7528\uff0c\u4ece\u800c\u589e\u52a0\u60a3\u8005\u7684\u6cbb\u7597\u7a97\u53e3\uff0c\u5e76\u6709\u53ef\u80fd\u6539\u5584\u4e34\u5e8a\u7ed3\u679c\u3002 \u201c\u764c\u75c7\u80bf\u7624\u6709\u65f6\u88ab\u79f0\u4e3a\u6c38\u4e0d\u6108\u5408\u7684\u5185\u4f24\u3002\u8840\u5c0f\u677f\u88ab\u5438\u5f15\u5230\u4f24\u53e3\u90e8\u4f4d\uff0c\u56e0\u6b64\u6211\u4eec\u6709\u5145\u5206\u7684\u7406\u7531\u76f8\u4fe1\uff0c\u81c2\u4e1b\u591a\u53ef\u4f18\u5148\u5411\u80bf\u7624\u8f93\u9001\u963f\u9709\u7d20\uff0c\u201dExopharm\u521b\u65b0\u90e8\u95e8\u8d1f\u8d23\u4ebaAndrew Coley\u535a\u58eb\u8868\u793a\u3002 \u5f71\u54cdExopharm\u65b9\u6cd5\u7597\u6548\u5e76\u6700\u7ec8\u51b3\u5b9a\u4e1b\u72b6\u808c\u662f\u5426\u6709\u6548\u7684\u4e00\u4e2a\u5173\u952e\u56e0\u7d20\u662f\u836f\u7269\u7684\u914d\u65b9\u3002 \u963f\u9709\u7d20\u901a\u5e38\u4ee5\u201c\u8102\u8d28\u4f53\u914d\u65b9\u201d\u7684\u5f62\u5f0f\u51fa\u552e\uff0c\u8fd9\u662f\u4e00\u79cd\u836f\u7269\u5236\u5907\u65b9\u6cd5\uff0c\u5728\u5fae\u89c2\u7684\u201c\u7c7b\u8102\u201d\u9897\u7c92\u4e2d\u542b\u6709\u6d3b\u6027\u836f\u7269\u3002\u5728\u8fd9\u79cd\u6539\u53d8\u7684\u5f62\u5f0f\u4e0b\uff0c\u8eab\u4f53\u66f4\u5bb9\u6613\u5438\u6536\u836f\u7269\uff0c\u5e76\u5141\u8bb8\u66f4\u591a\u7684\u836f\u7269\u5230\u8fbe\u8eab\u4f53\u7684\u76ee\u6807\u533a\u57df\uff0c\u5982\u80bf\u7624\u3002 \u8102\u8d28\u4f53\u914d\u65b9\u8fd8\u5ef6\u957f\u4e86\u8be5\u836f\u5728\u4f7f\u7528\u540e\u7684\u5faa\u73af\u534a\u8870\u671f\uff0c\u5e76\u964d\u4f4e\u4e86\u5176\u5fc3\u810f\u6bd2\u6027\u3002 \u8102\u8d28\u4f53\u836f\u7269\u9012\u9001\u7eb3\u7c73\u9897\u7c92\u662f\u5408\u6210\u7684\uff0c\u8fd9\u610f\u5473\u7740\u5b83\u4eec\u53ef\u4ee5\u88ab\u514d\u75ab\u7cfb\u7edf\u9776\u5411\uff0c\u5f15\u53d1\u4e0d\u5229\u7684\u514d\u75ab\u53cd\u5e94\u3001\u514d\u75ab\u6bd2\u6027\u548c\u8102\u8d28\u4f53\u6e05\u9664\u3002 \u201c\u764c\u75c7\u60a3\u8005\u901a\u5e38\u5df2\u7ecf\u901a\u8fc7\u8f93\u6ce8\u8840\u5c0f\u677f\u6765\u62b5\u6d88\u5316\u7597\u7684\u526f\u4f5c\u7528\uff0c\u6240\u4ee5\u6211\u4eec\u77e5\u9053\u5f02\u57fa\u56e0\u8840\u5c0f\u677f\u4e0d\u4ec5\u5b89\u5168\uff0c\u800c\u4e14\u5177\u6709\u6cbb\u7597\u4f5c\u7528\u3002\u201dPlexodox\u5c06\u4e24\u79cd\u7597\u6cd5\u5408\u800c\u4e3a\u4e00\uff0c\u201dExopharm\u516c\u53f8\u7684\u9996\u5e2d\u5546\u52a1\u5b98Chris Baldwin\u535a\u58eb\u8bf4\u3002 \u4ed6\u8865\u5145\u8bf4:\u201c\u6211\u4eec\u7684\u65b9\u6cd5\u662f\uff0c\u4e0e\u5176\u6cbb\u7597\u75c5\u4eba\u7684\u526f\u4f5c\u7528\uff0c\u4e0d\u5982\u4f7f\u7528\u8840\u5c0f\u677f\u7535\u52a8\u6c7d\u8f66\u5728\u764c\u7ec6\u80de\u5185\u90e8\u83b7\u5f97\u963f\u9709\u7d20\u3002\u201d Exopharm\u516c\u53f8\u516c\u5e03\u7684\u6d4b\u8bd5\u7ed3\u679c\u8fd8\u5904\u4e8e\u65e9\u671f\u9636\u6bb5\uff0c\u4f53\u5916\u7ed3\u679c\u8fd8\u6709\u5f85\u4e8e\u5728\u52a8\u7269\u6a21\u578b\u4e0a\u5f97\u5230\u8bc1\u5b9e\uff0c\u800c\u8be5\u516c\u53f8\u8bc1\u5b9e\uff0c\u5728\u4e1b\u72b6\u591a\u7528\u9014x\u88ab\u63d0\u8bae\u7528\u4e8e\u4eba\u4f53\u8bd5\u9a8c\u4e4b\u524d\uff0c\u8fd8\u9700\u8981\u8fdb\u884c\u989d\u5916\u7684\u6d4b\u8bd5\uff0c\u4f5c\u4e3a\u5f00\u53d1\u8ba1\u5212\u7684\u4e00\u90e8\u5206\u3002 Exopharm\u7684\u80a1\u4ef7\u5728\u65e9\u76d8\u4ea4\u6613\u4e2d\u4e0a\u6da8\u8d85\u8fc730%\uff0c\u8fbe\u52300.29\u6fb3\u5143\u3002<\/p>\n","protected":false},"author":5,"featured_media":7970,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[279],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Exopharm\u7814\u53d1\u65b0\u578bPlexaris\u4ea7\u54c1\uff0c\u5c06\u6297\u764c\u836f\u7269\u5bfc\u5165\u9776\u7ec6\u80de<\/title>\n<meta name=\"description\" content=\"\u4e34\u5e8a\u9636\u6bb5\u518d\u751f\u836f\u7269\u516c\u53f8Exopharm (ASX: EX1)\u516c\u5e03\u7684\u6d4b\u8bd5\u7ed3\u679c\u8868\u660e\uff0c\u8be5\u516c\u53f8\u7684Plexaris\u4ea7\u54c1\u901a\u8fc7\u201cLEAP\u6280\u672f\u201d\u7531\u5de5\u7a0b\u5916\u6ccc\u4f53\u7ec4\u6210\uff0c\u80fd\u591f\u6709\u6548\u5730\u5c06\u6cbb\u7597\u836f\u7269\u5bfc\u5165\u76ee\u6807\u7ec6\u80de\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Exopharm\u7814\u53d1\u65b0\u578bPlexaris\u4ea7\u54c1\uff0c\u5c06\u6297\u764c\u836f\u7269\u5bfc\u5165\u9776\u7ec6\u80de\" \/>\n<meta property=\"og:description\" content=\"\u4e34\u5e8a\u9636\u6bb5\u518d\u751f\u836f\u7269\u516c\u53f8Exopharm (ASX: EX1)\u516c\u5e03\u7684\u6d4b\u8bd5\u7ed3\u679c\u8868\u660e\uff0c\u8be5\u516c\u53f8\u7684Plexaris\u4ea7\u54c1\u901a\u8fc7\u201cLEAP\u6280\u672f\u201d\u7531\u5de5\u7a0b\u5916\u6ccc\u4f53\u7ec4\u6210\uff0c\u80fd\u591f\u6709\u6548\u5730\u5c06\u6cbb\u7597\u836f\u7269\u5bfc\u5165\u76ee\u6807\u7ec6\u80de\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/exopharm-developing-plexaris-deliver-anti-cancer-drug-target-cells\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2020-05-25T00:58:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T18:02:05+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/05\/Exopharm-ASX-EX1-Plexaris-anti-cancer-drug-doxorubicin-Plexodox.jpg\" \/>\n<meta name=\"author\" content=\"Small Caps\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Exopharm\u7814\u53d1\u65b0\u578bPlexaris\u4ea7\u54c1\uff0c\u5c06\u6297\u764c\u836f\u7269\u5bfc\u5165\u9776\u7ec6\u80de\" \/>\n<meta name=\"twitter:description\" content=\"\u4e34\u5e8a\u9636\u6bb5\u518d\u751f\u836f\u7269\u516c\u53f8Exopharm (ASX: EX1)\u516c\u5e03\u7684\u6d4b\u8bd5\u7ed3\u679c\u8868\u660e\uff0c\u8be5\u516c\u53f8\u7684Plexaris\u4ea7\u54c1\u901a\u8fc7\u201cLEAP\u6280\u672f\u201d\u7531\u5de5\u7a0b\u5916\u6ccc\u4f53\u7ec4\u6210\uff0c\u80fd\u591f\u6709\u6548\u5730\u5c06\u6cbb\u7597\u836f\u7269\u5bfc\u5165\u76ee\u6807\u7ec6\u80de\u3002\" \/>\n<meta name=\"twitter:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/05\/Exopharm-ASX-EX1-Plexaris-anti-cancer-drug-doxorubicin-Plexodox.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Small Caps\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/exopharm-developing-plexaris-deliver-anti-cancer-drug-target-cells\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/exopharm-developing-plexaris-deliver-anti-cancer-drug-target-cells\/\",\"name\":\"Exopharm\u7814\u53d1\u65b0\u578bPlexaris\u4ea7\u54c1\uff0c\u5c06\u6297\u764c\u836f\u7269\u5bfc\u5165\u9776\u7ec6\u80de\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2020-05-25T00:58:00+00:00\",\"dateModified\":\"2023-08-29T18:02:05+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\"},\"description\":\"\u4e34\u5e8a\u9636\u6bb5\u518d\u751f\u836f\u7269\u516c\u53f8Exopharm (ASX: EX1)\u516c\u5e03\u7684\u6d4b\u8bd5\u7ed3\u679c\u8868\u660e\uff0c\u8be5\u516c\u53f8\u7684Plexaris\u4ea7\u54c1\u901a\u8fc7\u201cLEAP\u6280\u672f\u201d\u7531\u5de5\u7a0b\u5916\u6ccc\u4f53\u7ec4\u6210\uff0c\u80fd\u591f\u6709\u6548\u5730\u5c06\u6cbb\u7597\u836f\u7269\u5bfc\u5165\u76ee\u6807\u7ec6\u80de\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/exopharm-developing-plexaris-deliver-anti-cancer-drug-target-cells\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/exopharm-developing-plexaris-deliver-anti-cancer-drug-target-cells\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/exopharm-developing-plexaris-deliver-anti-cancer-drug-target-cells\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Exopharm\u7814\u53d1\u65b0\u578bPlexaris\u4ea7\u54c1\uff0c\u5c06\u6297\u764c\u836f\u7269\u5bfc\u5165\u9776\u7ec6\u80de\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\",\"name\":\"Small Caps\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"caption\":\"Small Caps\"},\"description\":\"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=5\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Exopharm\u7814\u53d1\u65b0\u578bPlexaris\u4ea7\u54c1\uff0c\u5c06\u6297\u764c\u836f\u7269\u5bfc\u5165\u9776\u7ec6\u80de","description":"\u4e34\u5e8a\u9636\u6bb5\u518d\u751f\u836f\u7269\u516c\u53f8Exopharm (ASX: EX1)\u516c\u5e03\u7684\u6d4b\u8bd5\u7ed3\u679c\u8868\u660e\uff0c\u8be5\u516c\u53f8\u7684Plexaris\u4ea7\u54c1\u901a\u8fc7\u201cLEAP\u6280\u672f\u201d\u7531\u5de5\u7a0b\u5916\u6ccc\u4f53\u7ec4\u6210\uff0c\u80fd\u591f\u6709\u6548\u5730\u5c06\u6cbb\u7597\u836f\u7269\u5bfc\u5165\u76ee\u6807\u7ec6\u80de\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Exopharm\u7814\u53d1\u65b0\u578bPlexaris\u4ea7\u54c1\uff0c\u5c06\u6297\u764c\u836f\u7269\u5bfc\u5165\u9776\u7ec6\u80de","og_description":"\u4e34\u5e8a\u9636\u6bb5\u518d\u751f\u836f\u7269\u516c\u53f8Exopharm (ASX: EX1)\u516c\u5e03\u7684\u6d4b\u8bd5\u7ed3\u679c\u8868\u660e\uff0c\u8be5\u516c\u53f8\u7684Plexaris\u4ea7\u54c1\u901a\u8fc7\u201cLEAP\u6280\u672f\u201d\u7531\u5de5\u7a0b\u5916\u6ccc\u4f53\u7ec4\u6210\uff0c\u80fd\u591f\u6709\u6548\u5730\u5c06\u6cbb\u7597\u836f\u7269\u5bfc\u5165\u76ee\u6807\u7ec6\u80de\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/exopharm-developing-plexaris-deliver-anti-cancer-drug-target-cells\/","og_site_name":"smallcapsCN","article_published_time":"2020-05-25T00:58:00+00:00","article_modified_time":"2023-08-29T18:02:05+00:00","og_image":[{"url":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/05\/Exopharm-ASX-EX1-Plexaris-anti-cancer-drug-doxorubicin-Plexodox.jpg"}],"author":"Small Caps","twitter_card":"summary_large_image","twitter_title":"Exopharm\u7814\u53d1\u65b0\u578bPlexaris\u4ea7\u54c1\uff0c\u5c06\u6297\u764c\u836f\u7269\u5bfc\u5165\u9776\u7ec6\u80de","twitter_description":"\u4e34\u5e8a\u9636\u6bb5\u518d\u751f\u836f\u7269\u516c\u53f8Exopharm (ASX: EX1)\u516c\u5e03\u7684\u6d4b\u8bd5\u7ed3\u679c\u8868\u660e\uff0c\u8be5\u516c\u53f8\u7684Plexaris\u4ea7\u54c1\u901a\u8fc7\u201cLEAP\u6280\u672f\u201d\u7531\u5de5\u7a0b\u5916\u6ccc\u4f53\u7ec4\u6210\uff0c\u80fd\u591f\u6709\u6548\u5730\u5c06\u6cbb\u7597\u836f\u7269\u5bfc\u5165\u76ee\u6807\u7ec6\u80de\u3002","twitter_image":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/05\/Exopharm-ASX-EX1-Plexaris-anti-cancer-drug-doxorubicin-Plexodox.jpg","twitter_misc":{"Written by":"Small Caps"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/exopharm-developing-plexaris-deliver-anti-cancer-drug-target-cells\/","url":"https:\/\/smallcapscn.x5view.co\/exopharm-developing-plexaris-deliver-anti-cancer-drug-target-cells\/","name":"Exopharm\u7814\u53d1\u65b0\u578bPlexaris\u4ea7\u54c1\uff0c\u5c06\u6297\u764c\u836f\u7269\u5bfc\u5165\u9776\u7ec6\u80de","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2020-05-25T00:58:00+00:00","dateModified":"2023-08-29T18:02:05+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74"},"description":"\u4e34\u5e8a\u9636\u6bb5\u518d\u751f\u836f\u7269\u516c\u53f8Exopharm (ASX: EX1)\u516c\u5e03\u7684\u6d4b\u8bd5\u7ed3\u679c\u8868\u660e\uff0c\u8be5\u516c\u53f8\u7684Plexaris\u4ea7\u54c1\u901a\u8fc7\u201cLEAP\u6280\u672f\u201d\u7531\u5de5\u7a0b\u5916\u6ccc\u4f53\u7ec4\u6210\uff0c\u80fd\u591f\u6709\u6548\u5730\u5c06\u6cbb\u7597\u836f\u7269\u5bfc\u5165\u76ee\u6807\u7ec6\u80de\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/exopharm-developing-plexaris-deliver-anti-cancer-drug-target-cells\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/exopharm-developing-plexaris-deliver-anti-cancer-drug-target-cells\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/exopharm-developing-plexaris-deliver-anti-cancer-drug-target-cells\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Exopharm\u7814\u53d1\u65b0\u578bPlexaris\u4ea7\u54c1\uff0c\u5c06\u6297\u764c\u836f\u7269\u5bfc\u5165\u9776\u7ec6\u80de"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74","name":"Small Caps","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","caption":"Small Caps"},"description":"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.","url":"https:\/\/smallcapscn.x5view.co\/?author=5"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/1232"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1232"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/1232\/revisions"}],"predecessor-version":[{"id":7969,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/1232\/revisions\/7969"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/7970"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1232"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1232"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1232"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}